Gene · 4920
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma. | Bone Res | 2023 | 37246175 | PubTator, text mining | PubMed |
| Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. | Int J Mol Sci | 2023 | 37240338 | PubTator, text mining | PubMed |
| Transcription of WNT Genes in Hematopoietic Niche's Mesenchymal Stem Cells in Multiple Myeloma Patients with Different Responses to Treatment. | Genes (Basel) | 2023 | 37239457 | PubTator, text mining | PubMed |
| AhR and Wnt/β-Catenin Signaling Pathways and Their Interplay. | Curr Issues Mol Biol | 2023 | 37232717 | PubTator, text mining | PubMed |
| CTHRC1, a novel gene with multiple functions in physiology, disease and solid tumors (Review). | Oncol Lett | 2023 | 37216164 | PubTator, text mining | PubMed |
| Mechanistic Regulation of Wnt Pathway-Related Progression of Chronic Obstructive Pulmonary Disease Airway Lesions. | Int J Chron Obstruct Pulmon Dis | 2023 | 37215745 | PubTator, text mining | PubMed |
| Targeting strategies for bone diseases: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | 37198232 | PubTator, text mining | PubMed |
| The Multifaceted Role of WNT Signaling in Alzheimer's Disease Onset and Age-Related Progression. | Cells | 2023 | 37190113 | PubTator, text mining | PubMed |
| A New Wave of Targeting 'Undruggable' Wnt Signaling for Cancer Therapy: Challenges and Opportunities. | Cells | 2023 | 37190019 | PubTator, text mining | PubMed |
| Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention. | Biomolecules | 2023 | 37189400 | PubTator, text mining | PubMed |
| New Hydronephrosis in the Native Kidney Is Associated with the Development of De Novo Urinary Bladder Urothelial Carcinoma in Patients with Post-Kidney Transplantation. | Healthcare (Basel) | 2023 | 37174750 | PubTator, text mining | PubMed |
| Genetics implicates overactive osteogenesis in the development of diffuse idiopathic skeletal hyperostosis. | Nat Commun | 2023 | 37156767 | PubTator, text mining | PubMed |
| Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. | Cancer Metastasis Rev | 2023 | 37147457 | PubTator, text mining | PubMed |
| Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer. | BMC Med Genomics | 2023 | 37138287 | PubTator, text mining | PubMed |
| Pancreatic solid pseudopapillary neoplasm with concomitant left unilateral renal agenesis and bicornuate uterus: a case report. | Ann Med Surg (Lond) | 2023 | 37113970 | PubTator, text mining | PubMed |
| A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells. | Pharmaceutics | 2023 | 37111634 | PubTator, text mining | PubMed |
| Elevated Levels of Plasma Collagen Triple Helix Repeat Containing 1 (CTHRC1) Are Strongly Associated with eGFR and Albuminuria in Chronic Kidney Disease. | Medicina (Kaunas) | 2023 | 37109608 | PubTator, text mining | PubMed |
| The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies. | Life (Basel) | 2023 | 37109525 | PubTator, text mining | PubMed |
| The role of wnt signaling in diabetes-induced osteoporosis. | Diabetol Metab Syndr | 2023 | 37106471 | PubTator, text mining | PubMed |
| Downregulation of ROR2 attenuates LPS-induced A549 cell injury through JNK and ERK signaling pathways. | Immun Inflamm Dis | 2023 | 37102658 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4920/papers?page=11